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One of the main clinical features characterizing crystal-induced inflammation is its
spontaneous resolution. The aim of this review is to outline the various factors involved
in the self-limiting course of crystal-induced inflammation focusing on their effect on
IL-1β production. Endogenous molecules that are induced or locally recruited by the
process itself, inhibitory proteins naturally present in the joint and exogenous dietary
factors are discussed. Aside from the classical well-known molecules involved in the
resolution of crystal-induced acute attack such as TGFβ, IL-10, IL-1Ra, and lipoproteins,
particular attention is paid to recently uncovered mechanisms such as the aggregation
of neutrophil extracellular traps, the release of ectosomes from neutrophil surface, and
alpha-1-anti-trypsin-mediated IL-1 inhibition.
Keywords: crystal-induced inflammation, interleukin-1, transforming growth factor, lipoproteins, neutrophil
extracellular traps, dietary factors
INTRODUCTION
Crystal-induced inflammation is caused by the presence of monosodium urate (MSU) or
calcium pyrophosphate (CPP) crystals in articular or periarticular tissues. Although MSU
and CPP crystals form in different ways, their effects are very similar and associated with
an acute, intense inflammatory reaction characterized by massive leukocyte recruitment and
the local release of cytokines, chemokines, reactive oxygen species and proteolytic enzymes
(Liu-Bryan and Lioté, 2005).
Since the time cytoplasmic NACHT-LRRPYD-containing protein-3 (NLRP) 3 inflammasome
was first identified and its activation by MSU and CPP crystals was demonstrated (Martinon et al.,
2006), interleukin (IL)-1β has been considered the most important inflammatory mediator in
crystal-induced inflammation, and it represents one of the main targets for new drugs that have
been or are being developed to treat gout and calcium crystal-induced arthritis (Dinarello, 2014).
Although the molecular mechanisms leading to the activation of NLRP3 by pathogenic crystals
have not been fully elucidated, the two-step process linked to the production of IL-1β has been
clearly demonstrated. The first signal is triggered by pattern-recognition receptors (e.g., TLRs)
which initiate the transcription of IL-1β; the second signal triggers inflammasome activation, which
in turn activates caspase-1 and leads to the cleavage of the IL-1β precursors into the active cytokine
(Joosten et al., 2010; Netea et al., 2015; Scanu et al., 2016). Once released, the cytokine promotes the
induction of different pro-inflammatory genes amplifying the inflammatory process and leading to
long term articular damage. Similarly to IL-1β, IL-18 is produced by caspase-1 activation but its
role in crystal-induced inflammation has not been clearly defined.
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One of the main clinical features characterizing crystal-
induced inflammation is its spontaneous resolution. It is well-
known that patients experiencing an acute attack improve within
a few days time and that the disease progresses to a chronic state
only if untreated (Punzi et al., 2012). The various factors involved
in the self-limiting course of crystal-induced inflammation are
outlined in this review. Most of these are endogenous molecules
that are induced or locally recruited by the process itself or
are inhibitory proteins naturally present in the joint. Other
factors are exogenous dietary substances that can modulate the
resolution of the acute attack (Figure 1).
An in-depth analysis of these mechanisms reveals that the final
outcome is a direct or indirect action on IL-1β production. In
particular, a negative regulation of inflammasome activation and
pro-IL-1β expression have been described.
Transforming Growth Factor
Transforming growth factor (TGF) β1 is one of the main
molecules involved in the resolution of crystal-induced
inflammation. The effect of TGFβ1 was initially described in a
subcutaneous air pouch animal model in which it inhibited MSU
crystal-induced leukocyte chemotaxis (Lioté et al., 1996).
Some investigators hypothesized that the shift from a pro-
inflammatory state to an active production of anti-inflammatory
molecules is the mechanism leading to the resolution of
an acute attack (Chen et al., 2011). It has been shown, in
fact, that the differentiation of monocytes into macrophages
and the uptake of crystals by the latter induces TGFβ1
secretion (Chen et al., 2011). The presence of high levels
of TGFβ1, IL-1 receptor antagonist (Ra), IL-10 and soluble
receptors of tumor necrosis factor (TNF) has, in fact, been
demonstrated in the synovial fluid (SF) of patients with gout
and has been associated with the upregulation of intracellular
negative cytokine regulators such as the suppressors of cytokine
signalling (SOCS)3 and the cytokine inducible SH2-containing
protein (CIS). While enhancing TGFβ1 expression, these
proteins downregulate IL-1β and TNF secretion (Chen et al.,
2011).
In addition, the inverse relationship between TGFβ1 and IL-
1β was clearly demonstrated by a study examining different
inflammatory mediators in the SF collected during different
stages of acute gout attack (Scanu et al., 2012).
A tight regulation of IL-1β production by TGFβ1 has also been
demonstrated with regard to neutrophils. Activated neutrophils
have, in fact, been identified as an additional potential source
of local TGFβ1 production. An increased TGFβ1 expression
following neutrophil phagocytosis of apoptotic cells, a process
which in turn regulates IL-1β production by the neutrophils
themselves, has been described (Steiger and Harper, 2013).
The negative regulation of IL-1β production by the crystal-
induced TGFβ1 signaling pathway has been confirmed by other
investigators. In particular, a higher transglutaminase (TG) 2
expression in crystal-exposed macrophages has been linked to
TGFβ production (Yen et al., 2015) which, in turn, downregulates
IL-1β release through the inhibition of the Janus kinase (JAK)
2 signaling. TG is indeed highly expressed in gout and has
been shown to enhance phagocytosis of apoptotic leukocytes by
macrophages limiting neutrophil accumulation and promoting
resolution (Rose et al., 2006).
Importantly, TGFβ1 has been shown to inhibit cell surface
IL-1 receptor expression (Dubois et al., 1990) supporting
an additional role in limiting crystal-induced inflammatory
response.
Lipoproteins
Several studies have demonstrated the importance of lipoproteins
as modulators of crystal-induced inflammation. It has been
hypothesized that changes in SF lipoprotein concentration and
in the proteins that coat crystals play an integral role in the self-
limiting nature of an acute attack. In this context, lipoproteins
containing apolipoproteins (apo) B and E, have demonstrated
potential regulatory effects suppressing MSU crystal phagocytosis
and alpha-mannosidase release by neutrophils (Terkeltaub et al.,
1986, 1991). This is probably due to the ability of these proteins
to displace complement-activating IgG that initially cover the
crystals (Ortiz-Bravo et al., 1993). It has also been hypothesized
that the binding of low density (LDL) and high density
lipoproteins (HDL) to the crystal surface reduces MSU- and
CPP-induced lactate dehydrogenase release from neutrophils, a
marker for cytolysis (Burt et al., 1989). It has been shown that
the levels of LDL in the rat air-pouch model surge and remain
elevated 24 h after the injection of CPP crystals, while the number
of white blood cells and the concentration of β-Glucoronidase
and PGE2 significantly fell (Kumagai et al., 2001). In addition, it
has been reported that HDL inhibit MSU crystal-induced CCL2
production and expression in human synoviocytes and reduce
monocyte/macrophage recruitment (Scanu et al., 2010).
Although several studies have demonstrated that lipoproteins
may contribute to limiting crystal induced inflammation, their
effects on the production of IL-1β have been evaluated only for
HDL. Air pouch experiments have shown that HDL display anti-
inflammatory activity reducing the recruitment of leukocytes
and affecting pro- and anti-inflammatory cytokine balance after
MSU crystal injection. It has been reported, in particular, that
HDL reduce the release of IL-1β in pouch exudates and the
mRNA levels in membranes. Interestingly, HDL do not affect
the production of the crystal-induced anti-inflammatory factor
IL-1Ra. Unlike other lipoproteins, HDL may act not only by
adhering to the surface of the crystals, but also through a direct
interaction with the inflammatory cells (Scanu et al., 2015).
IL-1Ra
Although IL-1Ra is the natural IL-1 inhibitor as it functions as
an IL-1 receptor competitor (Dayer, 2002) and its effectiveness
in the treatment of gout has been established, few studies have
been conducted to assess its role in the spontaneous resolution
of crystal-induced inflammation. Anti-inflammatory cytokine
assessment in SF demonstrated that IL-1Ra levels are higher
in gouty patients than in osteoarthritis patients (Chen et al.,
2011). The injection of MSU crystals into a murine air pouch
causes IL-1Ra production after 3 h, although the levels detected
are not sufficient to inhibit the inflammatory effect of IL-1β at
that same time point (Scanu et al., 2015). In vitro stimulation
of monocytes/macrophages by synthetic MSU, CPP and basic
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FIGURE 1 | Endogenous and exogenous factors involved in the resolution of crystal-induced inflammation. The acute attack triggered in the joints by
MSU or CPP crystals resolves in a few days. Various factors are involved in this self-limiting process. Most of these are endogenous molecules (TGFβ1, IL-1Ra,
IL-10, PAF, PPARγ) or intracellular negative cytokine regulators (SOCS3, CIS, TG2) induced in monocytes/macrophages following crystal exposure. Others are
hormones (α-MSH) or proteins produced by neutrophils (TGFβ1, AAT) or molecules naturally present in the joints (lipoproteins and apoproteins). Dynamic processes
involving neutrophils such as aggNET and ectosomes release are also involved in the resolution of crystal-induced inflammation. Finally, exogenous dietary
components (phenolic compounds and fibers) play an additional role in modulating the inflammatory process induced by pathogenic crystals. → Lead to the
production of; ↑ increase; ↓ decrease.
calcium phosphate (BCP) crystals induces a rapid increase in pro-
inflammatory cytokines such as IL-1β, IL-8 and IL-6, whereas
longer periods are required to release high levels of IL-1Ra (a
personal observation).
Neutrophil Extracellular Traps and
Microvesicles
The aggregation of neutrophil extracellular traps (NETs) induced
by pathogenic crystals has been recently associated with the
resolution of neutrophilic inflammation that characterizes the
acute crystal-induced inflammatory process.
NET formation (NETosis) is accompanied by the release of a
variety of pro-inflammatory mediators that orchestrate the local
innate immune response. When neutrophils are under conditions
of high cell density, crystal-induced NETs form dense aggregates
that sequester and degrade neutrophil inflammatory mediators,
in particular IL-1β. It has been demonstrated that this process is
mediated by ROS which, in this particular case, downregulates
inflammation (Schauer et al., 2014).
Another phenomenon that is associated with the resolution
of crystal-induced arthritis is the release of phosphatidylserine
positive ectosomes from the surface of neutrophils during the
inflammatory process. It has been demonstrated that these
ectosomes suppress inflammasome and consequently inhibit
IL-1β release in C5a primed macrophages (Cumpelik et al., 2016).
Although ectosomes trigger the release of TGF by monocyte
and macrophages, it was not found that TGF was necessary to
suppress inflammasome activation.
Other Endogenous Factors
A variety of other regulatory factors involved in the spontaneous
resolution of an acute attack of crystal-induced arthritis have
been identified. Among them, peroxisome proliferator-activated
receptor γ (PPARγ), a nuclear hormone receptor, has been
shown to be expressed in human monocytes after MSU
crystal stimulation. PPARγ ligands reduce the crystal-induced
production of IL-1β and TNF in vitro (Akahoshi et al., 2003).
Similarly, melacortin receptor (MC-R) agonists can also
influence the resolution of an acute gout attack. Selective ligands
for MC-R3, such as α-melacortin-stimulating hormone (α-MSH),
lower the levels of IL-1β and the chemokine (C-X-C motif) ligand
1 (CXCL1) and the polymorphonuclear cell (PMN) migration
in a murine model of MSU crystal-induced peritonitis (Getting
et al., 2001, 2006). In addition, it was found that α-MSH inhibits,
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FIGURE 2 | Different levels of IL-1 inhibition by the endogenous and exogenous factors involved in the resolution of crystal-induced inflammation.
IL-1β production pathway can be affected by molecules that act upstream on NLRP3 activation (ectosomes, polyphenols, β-idroxybutyrate) and IL-1β mRNA
expression (HDL, butyrate), or downstream on pro-IL-1β cleavage (AAT), IL-1β formation (PPARγ, αMSH, SOCS3/CIS, acetate) and concentrations (NET), or
inhibiting IL-1β bond to its receptor IL-1R1 (IL-1Ra, TGFβ1). Although the final effect of PPARγ, αMSH and acetate is an inhibition of IL-1β levels, their precise
mechanism of action has not been elucidated.
in vitro, the capacity of monocytes to release IL-1β and other
pro-inflammatory cytokines in response to MSU crystals, without
affecting the secretion of caspase-1, the enzyme responsible
for converting pro-IL-1β to cytokine’s active form (Capsoni
et al., 2009). By contrast, β-hydroxybutyrate (BHB), a ketone
body produced in the liver, has been observed to inhibit IL-1β
processing in response to MSU crystals by reducing caspase-1
activation. BHB has been shown to block NLRP3 inflammasome
preventing the decline of K+ intracellular eﬄux induced by
NLRP3 activators (Youm et al., 2015).
Other molecules that may trigger resolution are induced
during inflammatory processes promoted by crystals, even
though they may play a minor role. Higher levels of IL-10 were
observed in the SF from patients with acute gout with respect
to OA patients (Chen et al., 2011). But although it has been
demonstrated that IL-10 overexpression blocks MSU crystal-
induced inflammation, including the suppression of TNF release
in vitro and CXCL1 production in vivo (Murakami et al., 2002),
there is no evidence of IL-10 in supernatants from differentiated
macrophages incubated with MSU crystals (Yagnik et al., 2004).
Macrophage derived platelet activating factor (PAF) and
related molecules could, according to one hypothesis, play a role
in suppressing the inflammatory response. In vitro experiments
demonstrated that MSU crystal-stimulated macrophages
release PAF, which in turn downregulates the TNF secretion
(Yagnik, 2014).
The anti-inflammatory effect of IL-10 and PAF has not
been assessed in the crystal-induced IL-1β production or
action/pathway.
A recently described mechanism involved in the inhibition
of crystal-induced inflammation concerns alpha-1-anti-trypsin
(AAT), the major, natural inhibitor of serine proteases produced
by neutrophils that can be found in human serum during
infections and inflammation. Serine proteases have been found
to be responsible for the caspase-1-independent conversion of
IL-1β precursor into the active cytokine in neutrophils (Joosten
et al., 2009) which are the main inflammatory cells in crystal
arthritis. It has been demonstrated that AAT not only reduces the
release and the extracellular processing of IL-1β but also increases
circulating levels of endogenous IL-1Ra, the natural inhibitor of
IL-1 (Joosten et al., 2016).
Exogenous Factors
Although, it is well-established that nutrients or dietary
metabolites possess immune-regulatory properties and can
modulate the inflammatory response (Camell et al., 2015), their
role in crystal-induced inflammation has only recently been taken
into consideration.
Well-known for their antioxidant, anti-inflammatory and
anti-cancer effects, plant polyphenols are the most studied
dietary compounds. In particular, green tea epigallocatechin-3-
gallate (EGCG) has been observed to reduce the inflammatory
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response to CPP crystals by inhibiting IL-1β, IL-8, and
CCL2 in vitro (Oliviero et al., 2013). An inhibitory effect
exerted by EGCG was also demonstrated in urate crystal-
induced peritoneal inflammation. A reduction in IL-1β levels
in the peritoneal lavage fluid has been observed together
with a lower NLRP3 inflammasome expression (Jhang et al.,
2016).
An inhibition of NLRP3 has also been reported by
investigators assessing the anti-inflammatory properties of two
other dietary polyphenols, morin (Dhanasekar and Rasool, 2016)
and ferulic acid (Doss et al., 2016) in a rat model of acute
gout.
Other studies have investigated the beneficial effects
of natural compounds in experimental gout models
(Martin et al., 2009; Sabina et al., 2011; Huang et al.,
2012). Although those studies did not take into full
consideration their effect on IL-1β pathway, the overall
result was an inhibition of the crystal-induced inflammatory
process.
Some interesting findings were produced using butyrate,
a short-chain fatty acid produced in the colon by the
fermentation of insoluble dietary fibers (Cleophas et al., 2016).
This substance has been shown to suppress urate crystal-
induced IL-1β production and expression by the inhibition of
the histone deacetylase (HDAC) 8, an enzyme that regulates
the expression and activity of various proteins. Although
the exact mechanism of action is not clear, butyrate did
not increase IL-Ra or TGFβ1, classically involved in the
resolution phase of the inflammatory response to pathogenic
crystals.
Recently, it has been demonstrated that a high-fiber diet and
acetate, a short-chain fatty acid resulting from the metabolism
of fiber by gut microbiota, induce faster resolution of the
inflammatory response triggered in mice after injection of MSU
crystals into the knee joint. In particular, acetate promotes
caspase-dependent apoptosis of neutrophils associated with
reduced NF-kB activity, lower IL-1β tissue concentations,
increased production of anti-inflammatory mediators, such as
TGF-β, IL-10 and annexin A1, and enhanced efferocytosis (Vieira
et al., 2017).
CONCLUSION
Several mechanisms seem to be involved in resolving crystal-
induced inflammation. Although some are linked to exogenous
dietary factors, an acute attack is limited by molecules that are
activated or expressed following the attack itself through a finely
tuned self-regulating mechanism.
As outlined above, these molecules can act at different
molecular levels, by affecting cell-crystal interactions, gene
expression and cytokine trapping. As regard to IL-1β production
process, Figure 2 evidences the substances involved upstream at
the mRNA and inflammasome inhibition level, and downstream
at IL-1β production, IL-1β release and IL-1R1 signaling level.
Although the precise mechanism of action of some of these
factors has not been fully characterized, the final outcome is a
diminished IL-1β production.
Considering the importance of IL-1 blocking agents in
reducing acute attacks, firstly noted with regard to IL-1Ra
anakinra, and then to the anti-IL-1β monoclonal antibody
canakinumab, every molecule capable to reduce IL-1β production
could represent a potential therapeutic target and have a positive
impact on the clinical practice.
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